Commercialization Committee

The Commercialization Committee is assigned with coordinating ITN Consortium efforts with NIH programs and with commercial pharmaceutical companies or biotechnology companies to help facilitate the movement of promising candidate medications or targets to the next phase of development. This group exploits promising preclinical research projects including human brain imaging and genetics, human and animal behavioral pharmacology, cell biology, and molecular pharmacology. The goal is to leverage the investment in discovery to attract the partners and potential resources required to support larger clinical studies, which in turn will lead to FDA approval for drug therapies for AUDs and related comorbid conditions.